AAVXF vs BIIB: Which Stock is Better?

Side-by-side comparison of Abivax S.A. and Biogen Inc in 2026

Comparison Updated:

AAVXF

Abivax S.A.

$115.65

BIIB

Biogen Inc

$187.88

Key Metrics Comparison

MetricAAVXFBIIBWinner
Market Cap$9.78B$27.89BBIIB
P/E RatioN/A21.60BIIB
EPS (TTM)$N/A$8.80BIIB
Revenue Growth-0.6%-0.1%BIIB
Gross Margin100.0%78.9%AAVXF

Analyze AAVXF

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AAVXF or BIIB a better investment?

Comparing AAVXF and BIIB: Abivax S.A. has a market cap of $9.78B while Biogen Inc has $27.89B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AAVXF and BIIB?

AAVXF (Abivax S.A.) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AAVXF or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: AAVXF or BIIB?

BIIB has higher revenue growth at -0.1% vs -0.6% for AAVXF.

Which company is more profitable: AAVXF or BIIB?

Abivax S.A. (AAVXF) has higher gross margins at 100.0% compared to 78.9% for BIIB.

Which is the larger company: AAVXF or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $27.89B compared to $9.78B for AAVXF.

Should I buy AAVXF or BIIB in 2026?

Both AAVXF and BIIB have investment merit. AAVXF trades at $115.65 while BIIB trades at $187.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AAVXF and BIIB stock?

Key differences: Market Cap ($9.78B vs $27.89B), P/E Ratio (N/A vs 21.6x), Revenue Growth (-0.6% vs -0.1%), Gross Margin (100.0% vs 78.9%).

Popular Stock Comparisons